Tharini Sathiamoorthy is Director of Health Policy at Cepheid, a molecular diagnostics company that develops, manufactures, and markets fully integrated systems for molecular diagnostics testing. Tharini joined Cepheid in May 2021 and is responsible for federal and global government affairs and health policy on issues related to antimicrobial resistance, COVID-19, and infectious diseases. Tharini has over 20 years of experience in global, federal, and state health policy, government affairs, and public affairs. Tharini previously served as Vice President at AdvaMedDx, the trade association representing diagnostics manufacturers, where she supported government affairs advocacy, health policy, and public affairs efforts at the global, federal, and state levels. She has also worked at U.S. Pharmacopeia, APCO Worldwide, Marwood Group, Lewin Group, and the American College of Physicians. Tharini received a Bachelor of Arts in International Relations and Biology from Boston University and a Master of Health Sciences in Health Policy with a Certificate in Health Finance and Management from the Johns Hopkins Bloomberg School of Public Health.